Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Malla Kuosmanen"'
Autor:
Malla Kuosmanen, Marja Vääräsmäki, Maija Riitta Ordén, Kati Sulin, Katri Haimila, Susanna Sainio, Suvi Toivonen, Kaarin Mäkikallio-Anttila, Riina M. Jernman, Kati Tihtonen, Camilla Isaksson
Background: Targeted routine antenatal anti-D prophylaxis was introduced to the national prophylaxis program in Finland in late 2013. The aim of this study was to assess the incidence, time-points, and risk factors for Rhesus D immunization after the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db5ceb28b4f8a9c89c53da3469e01d2f
http://urn.fi/urn:nbn:fi-fe2021102552185
http://urn.fi/urn:nbn:fi-fe2021102552185
Autor:
Inna Sareneva, Susanna Sainio, Vedran Stefanovic, Kati Sulin, Malla Kuosmanen, Katri Haimila, Riina M. Jernman, Anu Korhonen
Publikováno v:
Immunohematology. 31:123-127
Anti-G is commonly present with anti-D and/or anti-C and can confuse serological investigations. In general, anti-G is not considered a likely cause of severe hemolytic disease of the fetus and newborn (HDFN), but it is important to differentiate it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9110daaa77fbb2ba4bb0ce5ce8e6c780
https://doi.org/10.21307/immunohematology-2019-080
https://doi.org/10.21307/immunohematology-2019-080
Autor:
Malla Kuosmanen, Suvi Natunen, Kati Sulin, Anu Korhonen, Jarno Tuimala, Inna Sareneva, Susanna Sainio, Katri Haimila
Publikováno v:
Acta obstetricia et gynecologica Scandinavica. 96(10)
Introduction The aim of this study was to assess the accuracy of the non-invasive fetal RHD test at 24-26 weeks of gestation as part of the national antenatal screening programme to target routine antenatal anti-D prophylaxis (RAADP) at 28-30 weeks a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93adfcc91f6562a98b6223bf83bc5146
https://pubmed.ncbi.nlm.nih.gov/28718198
https://pubmed.ncbi.nlm.nih.gov/28718198
Autor:
Riina, Jernman, Vedran, Stefanovic, Anu, Korhonen, Katri, Haimila, Inna, Sareneva, Kati, Sulin, Malla, Kuosmanen, Susanna, Sainio
Publikováno v:
Immunohematology. 31(3)
Anti-G is commonly present with anti-D and/or anti-C and can confuse serological investigations. in general, anti-G is not considered a likely cause of severe hemolytic disease of the fetus and newborn (HDFN), but it is important to differentiate it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::743a7eff600bb22b7841a24cda65c0ce
https://pubmed.ncbi.nlm.nih.gov/26829179
https://pubmed.ncbi.nlm.nih.gov/26829179
Autor:
Susanna Sainio, Katri Haimila, Jukka Uotila, Riina M. Jernman, Anu Korhonen, Malla Kuosmanen, Kati Sulin, Inna Sareneva
Publikováno v:
Gynecology & Obstetrics Case report.
Background: Ula, part of the Kell blood group system, is a low-frequency antigen found predominantly in the Finnish population. Anti-Ula is a rare antibody to cause hemolytic disease of the fetus and newborn (HDFN). Methods and Findings: We report on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95f78bfeb94306047e79df0fa8a9c99e
https://doi.org/10.21767/2471-8165.1000023
https://doi.org/10.21767/2471-8165.1000023
Autor:
Erja Halmesmäki, Irmeli Nupponen, Vedran Stefanovic, Pertti Palo, Susanna Sainio, Maija-Riitta Ordén, Jukka Uotila, Ansa Aitokallio-Tallberg, Tytti Raudaskoski, Jarno Tuimala, Eeva Ekholm, Malla Kuosmanen, Aydin Tekay
Publikováno v:
Acta obstetricia et gynecologica Scandinavica. 94(4)
Objective Outcome after intrauterine transfusions due to severe hemolytic disease of the fetus and newborn. Design Nationwide population-based retrospective cohort study. Setting All women treated with intrauterine transfusions for hemolytic disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::839a7d5b628c8a9ae5abb6d0561e1cab
https://pubmed.ncbi.nlm.nih.gov/25603954
https://pubmed.ncbi.nlm.nih.gov/25603954
Autor:
John M. Bowman, M. Contreras, M. A.M. Overbeeke, A. Hadley, Henk W. Reesink, S.J. Urbaniak, S.F. Garner, B. Zupanska, C. P. Engelfriet, Malla Kuosmanen, George Garratty
Publikováno v:
Vox Sanguinis. 69:61-69
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e8d7bb40db74dcfcfdcda93b0be3eda
https://doi.org/10.1159/000462793
https://doi.org/10.1159/000462793
Autor:
Susanna, Sainio, Malla, Kuosmanen
Publikováno v:
Duodecim; laaketieteellinen aikakauskirja. 128(2)
Prophylaxis of RhD negative mothers with anti-D immunoglobulin after childbirth is the most important procedure reducing the immunization of the mother and the risk of severe hemolytic disease of the newborn. In spite of this, anti-D antibodies havin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e44f04435b0814c24034294b2aa2a40b
https://pubmed.ncbi.nlm.nih.gov/22372070
https://pubmed.ncbi.nlm.nih.gov/22372070
Autor:
S. Villa, Frank P.H.A. Vandenbussche, Ulrik Sprogøe, H. H. H. Kanhai, D. Gounder, B. Csapo, C. Pessoa, W. Stein, C. Sefonte, Simon Panzer, Ansa Aitokallio-Tallberg, D. Bettelheim, Tobias J. Legler, Svein Magne Skulstad, Malla Kuosmanen, Peter Flanagan, S. Koskinen, Maria Antonietta Villa, F. Guerra, L. Trespidi, Emma Parry, B. Zupanska, Olav Lapaire, Xiao Yan Zhong, Morten Hanefeld Dziegiel, Wolfgang Holzgreve, Tor Hervig, M. de Haas, Małgorzata Uhrynowska, B. Acaia, Henk W. Reesink, S. Wendel, Anneke Brand, R. Donegan, Pavel Calda, O Flesland
Publikováno v:
Vox Sanguinis, 99, 2, pp. 177-92
Vox Sanguinis, 99, 177-92
Vox sanguinis, 99(2), 177-192. Wiley-Blackwell
Bettelheim, D, Panzer, S, Reesink, H W, Csapo, B, Pessoa, C, Guerra, F, Wendel, S, Calda, P, Sprogøe, U, Dziegiel, M, Aitokallio-Tallberg, A, Koskinen, S, Kuosmanen, M, Legler, T J, Stein, W, Villa, S, Villa, M A, Trespidi, L, Acaia, B, Vandenbussche, F P H A, Brand, A, Haas, I M D, Kanhai, H H H, Gounder, D, Flanagan, P, Donegan, R, Parry, E, Sefonte, C, Skulstad, S M, Hervig, T, Flesland, Ø, Zupańska, B, Uhrynowska, M, Lapaire, O, Zhong, X Y & Holzgreve, W 2010, ' Monitoring and treatment of anti-D in pregnancy ', Vox Sanguinis, vol. 99, no. 2, pp. 177-92 . https://doi.org/10.1111/j.1423-0410.2010.01322.x
Vox Sanguinis, 99, 177-92
Vox sanguinis, 99(2), 177-192. Wiley-Blackwell
Bettelheim, D, Panzer, S, Reesink, H W, Csapo, B, Pessoa, C, Guerra, F, Wendel, S, Calda, P, Sprogøe, U, Dziegiel, M, Aitokallio-Tallberg, A, Koskinen, S, Kuosmanen, M, Legler, T J, Stein, W, Villa, S, Villa, M A, Trespidi, L, Acaia, B, Vandenbussche, F P H A, Brand, A, Haas, I M D, Kanhai, H H H, Gounder, D, Flanagan, P, Donegan, R, Parry, E, Sefonte, C, Skulstad, S M, Hervig, T, Flesland, Ø, Zupańska, B, Uhrynowska, M, Lapaire, O, Zhong, X Y & Holzgreve, W 2010, ' Monitoring and treatment of anti-D in pregnancy ', Vox Sanguinis, vol. 99, no. 2, pp. 177-92 . https://doi.org/10.1111/j.1423-0410.2010.01322.x
Prophylactic anti-D is a very safe and effective therapy for the suppression of anti-D immunization and thus prevention of haemolytic disease of the foetus and newborn. However, migration from countries with low health standards and substantial cuts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e3588c111a0ad53e6d472b9aa138610
https://pubmed.ncbi.nlm.nih.gov/20331536
https://pubmed.ncbi.nlm.nih.gov/20331536
Autor:
S. Koskinen, B. Zupanska, Tanja G. M. Vrijkotte, M. A. M. Overbeeke, Simon Panzer, W. R. Mayr, C. Martin-Vega, M. de Silva, Philippe Rouger, H. W. Reesink, W. J. Judd, V. Tantalo, V.-M. Ulander, Barbara Ulm, J. M. Koelewijn, T. Fujii, R. Parra Lopez, C. P. Engelfriet, F. Morelati, M. Contreras, Gouke J. Bonsel, M. de Haas, Malla Kuosmanen, C. E. Van Der Schoot
Publikováno v:
Vox Sanguinis. 85:328-329
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35e152d550402b452b00e6a3abfb2fdd
https://doi.org/10.1111/j.0042-9007.2003.364_1.x
https://doi.org/10.1111/j.0042-9007.2003.364_1.x